BSE Announcements Details
YOU ARE ON :
HOME
/
MARKETS
/
Company Information
/
BSE Announcements Details
Equity Analysis
Gainers & Losers
New Highs & Lows
52 Week High & Low
Advances & Declines
Top Value
Company Information
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Price Monthly
Intraday / EOD charts
Corporate Action
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
De-Listed Shares
Market Turnover
Change Of Name
Split Of Face Value
News Analysis
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Corporate Results
Stock Alert
Pre-Session Commentary
Mid-Session Commentary
End-Session Commentary
Other Markets
ADR Prices
Initial Public Offering
Forthcoming Issues
Open Issues
Closed Issues
New Listing
Basis of Allotment
Draft Prospectus
New Issue Monitor
Equity Analysis
Gainers & Losers
New Highs & Lows
52 Week High & Low
Advances & Declines
Top Value
Company Information
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Price Monthly
Intraday / EOD charts
Corporate Action
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
De-Listed Shares
Market Turnover
Change Of Name
Split Of Face Value
News Analysis
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Corporate Results
Stock Alert
Pre-Session Commentary
Mid-Session Commentary
End-Session Commentary
Other Markets
ADR Prices
Initial Public Offering (IPO)
Forthcoming Issues
Open Issues
Closed Issues
New Listing
Basis of Allotment
Draft Prospectus
New Issue Monitor
Back
Senores Pharmaceuticals Inc. to acquire USFDA approved ANDA for Tramadol Tablets